Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Short Report
  • Published:

c-abl is involved in the association of p53 and trk A

Abstract

The p53 tumour suppressor phosphoprotein associates with proteins involved in DNA replication, transcription, cell cycle machinery and regulation of its own expression. Recently it has been shown that p53 can also bind to trk A tyrosine kinase which is the receptor for nerve growth factor (NGF). This study demonstrates that p53 appears to associate with trk A via c-abl. Endogenous c-abl was detected when the trk A and p53 complex was immunoprecipitated from lysates of NGF stimulated NIH3T3 cells expressing trk A or NIH3T3 cells expressing trk A and a temperature sensitive p53 (val 135). Endogenous c-abl and trk A association was observed in NGF stimulated p53 negative fibroblasts transfected with trk A alone; suggesting that c-abl can independently bind to trk A in the absence of p53. Interestingly, association between endogenous p53 and trk A was not detected in NGF stimulated abl negative fibroblasts transfected with trk A or when these cells were exposed to gamma radiation. This result suggests that p53 preferentially binds to trk A in the presence of c-abl and that p53 and trk A do not appear to associate directly even if p53 is activated and its levels increased by gamma radiation. Overall, these data suggest that c-abl is possibly acting as an adaptor or bridge between p53 and trk A.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  • Agami R, Blandino G, Oren M and Shaul Y . 1999 Nature 399: 809–813

  • Aloni-Grinstein R, Schwartz D and Rotter V . 1995 EMBO J 14: 1392–1401

  • Amundson SA, Myers TG and Fornace Jr AJ . 1998 Oncogene 17: 3287–3299

  • Ashcroft M, Stephens RM, Hallberg B, Downward J and Kaplan DR . 1999 Oncogene 18: 4586–4597

  • Barbacid M . 1993 Oncogene 8: 2033–2042

  • Barde YA . 1989 Neuron 2: 1525–1534

  • Baudier J, Delphin C, Grunwald D, Khochbin S and Lawrence JJ . 1992 Proc Natl Acad Sci USA 89: 11627–11631

  • Bottger A, Bottger V, Sparks A, Liu WL, Howard SF and Lane DP . 1997 Curr Biol 7: 860–869

  • Dai Z and Pendergast AM . 1995 Genes Dev 9: 2569–2582

  • Dutta A, Ruppert JM, Aster JC and Winchester E . 1993 Nature 365: 79–82

  • Goga A, Liu X, Hambuch TM, Senechal K, Major E, Berk AJ, Witte ON and Sawyers CL . 1995 Oncogene 11: 791–799

  • Goldsmith BA and Koizumi S . 1997 J Neurochem 69: 1014–1019

  • Greene LA and Tischler A . 1976 Proc Natl Acad Sci USA 73: 2424–2428

  • Gu W and Roeder RG . 1997 Cell 90: 595–606

  • Halegoua S, Armstrong RC and Kremer NE . 1991 Curr Topics Microbiol Immunol 165: 119–170

  • Hallberg B, Ashcroft M, Loeb DM, Kaplan DR and Downward J . 1998 Oncogene 17: 691–697

  • Haupt Y, Maya R, Kazaz A and Oren M . 1997 Nature 387: 296–299

  • He Z, Brinton BT, Greenblatt J, Hassell JA and Ingles CJ . 1993 Cell 73: 1223–1232

  • Hempstead BL, Rabin SJ, Kaplan L, Reid S, Parada LF and Kaplan DR . 1992 Neuron 9: 883–896

  • Kaplan DR, Martin-Zanca D and Parada LF . 1991a Nature 350: 158–160

  • Kaplan DR, Hempstead BL, Martin-Zanca D, Chao MV and Parada LF . 1991b Science 252: 554–558

  • Kaplan DR and Miller FD . 1997 Curr Opin Cell Biol 9: 213–221

  • Kharbanda S, Ren R, Pandey P, Shafman TD, Feller SM, Weichselbaum RR and Kufe DW . 1995 Nature 376: 785–788

  • Kharbanda S, Yuan Z-M, Weichselbaum R and Kufe D . 1998 Oncogene 17: 3309–3318

  • Klein R, Jing S, Nanduri V, O'Rourke E and Barbacid M . 1991 Cell 65: 189–197

  • Kubbutat MHG, Jones SN and Vousden KH . 1997 Nature 387: 299–303

  • Lewis JM, Baskaran R, Taagepera S, Schwartz MA and Wang JYJ . 1996 Proc Natl Acad Sci USA 93: 15174–15179

  • Lill NL, Grossman SR, Ginsberg D, DeCaprio J and Livingston DM . 1997 Nature 387: 823–827

  • Masuda H, Miller C, Koeffler HP, Battifora H and Cline MJ . 1987 Proc Natl Acad Sci USA 84: 7716–7719

  • Mattioni T, Jackson PK, Bchini-Hooft van Huijsduijnen O and Picard D . 1995 Oncogene 10: 1325–1333

  • Michalovitz D, Halevy O and Oren M . 1990 Cell 62: 671–680

  • Momand J, Zambetti GP, Olson DC, George D and Levine AJ . 1992 Cell 69: 1237–1245

  • Montano X . 1997 Oncogene 15: 245–256

  • Nakamura T, Sanokawa R, Sasaki Y, Ayusawa D, Oishi M and Mori N . 1996 Oncogene 13: 1111–1121

  • Obermeier A, Halfter H, Wiesmuller K-H, Jung G, Schlessinger J and Ullrich A . 1993a EMBO J 12: 933–941

  • Obermeier A, Lammers R, Wiesmuller K-H, Jung G, Schlessinger J and Ullrich A . 1993b J Biol Chem 268: 22963–22966

  • Plattner R, Kadlec L, DeMali KA, Lazlauskas A and Pendergast AM . 1999 Genes Dev 13: 2400–2411

  • Prives C . 1994 Cell 78: 543–546

  • Prives C and Hall PA . 1999 J Pathol 187: 112–126

  • Qian X, Riccio A, Zhang Y and Ginty DD . 1998 Neuron 21: 1017–1029

  • Schiff-Maker L, Burns MC, Konopka JB, Clark S, Witte ON and Rosenberg N . 1986 J Virol 57: 1182–1186

  • Seto E, Usheva A, Zambetti GP, Momand J, Horikoshi N, Weinmann R, Levine AJ and Shenk T . 1992 Proc Natl Acad Sci USA 89: 12028–12032

  • Shaulsky G, Ben-Zeíev A and Rotter V . 1990 Oncogene 5: 1707–1711

  • Shaulsky G, Goldfinger N, Peled A and Rotter V . 1991 Proc Natl Acad Sci USA 88: 8982–8986

  • Shi Y, Alin K and Goff SP . 1995 Genes Dev 9: 2583–2597

  • Shieh S-Y, Ikeda M, Taya Y and Prives C . 1997 Cell 91: 325–334

  • Siliciano JD, Canman CE, Taya Y, Sakaguchi K, Appella E and Kastan MB . 1997 Genes Dev 11: 3471–3481

  • Stephens RM, Loeb DM, Copeland TD, Pawson T, Greene LA and Kaplan DR . 1994 Neuron 12: 691–705

  • Taagepera S, McDonald D, Loeb JE, Whitaker LL, McElroy AK, Wang JYJ and Hope TJ . 1998 Proc Natl Acad Sci USA 95: 7457–7462

  • Vambutas V, Kaplan DR, Sells MA and Chernoff J . 1995 J Biol Chem 270: 25629–25633

  • Waterman MJF, Stavridi ES, Waterman JLF and Halazonetis TD . 1998 Nature Genet 19: 175–178

  • Welch PJ and Wang JYJ . 1993 Cell 75: 779–790

  • Welch PJ and Wang JYJ . 1995 Mol Cell Biol 15: 5542–5551

  • Yamashita H, Avraham S, Jiang S, Dikic I and Avraham H . 1999 J Biol Chem 274: 15059–15065

  • Yewdell JW, Gannon JV and Lane DP . 1986 J Virol 59: 444–452

  • Yuan Z-M, Huang Y, Fan M-M, Sawyers C, Kharbanda S and Kufe D . 1996a J Biol Chem 271: 26457–26460

  • Yuan Z-M, Huang Y, Whang Y, Sawyers C, Weichselbaum R, Kharbanda S and Kufe D . 1996b Nature 382: 272–274

  • Yuan Z-M, Utsugisawa T, Huang Y, Ishiko T, Nakada S, Kharbanda S, Weichselbaum R and Kufe D . 1997a J Biol Chem 272: 23485–23488

  • Yuan Z-M, Huang Y, Ishiko T, Kharbanda S, Weichselbaum R and Kufe D . 1997b Proc Natl Acad Sci USA 94: 1437–1440

  • Yuan Z-M, Utsugisawa T, Nakada S, Huang Y, Kharbanda S, Weichselbaum R and Kufe D . 1998 Oncogene 16: 1643–1648

  • Yuan Z-M, Shioya H, Ishiko T, Sun X, Gu J, Huang YY, Lu H, Kharbanda S, Weichselbaum R and Kufe D . 1999 Nature 399: 814–817

  • Zerrahn J, Deppert W, Weidemann D, Patschinsky T, Richards F and Milner J . 1992 Oncogene 7: 1372–1381

Download references

Acknowledgements

We are grateful to Jean Wang and Bruce Mayer for pBK CMV abl, pBK CMV his-, pMSCV his-, abl−/− fibroblasts and helpful advice, to David Kaplan for anti-trk 203 antibody, to David Lane and Carol Midgley for sheep anti-p53 and to Andy Pearson for support and critical reading of this manuscript. This work was supported by a grant from the NECCRF.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Brown, A., Browes, C., Mitchell, M. et al. c-abl is involved in the association of p53 and trk A. Oncogene 19, 3032–3040 (2000). https://doi.org/10.1038/sj.onc.1203619

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1203619

Keywords

This article is cited by

Search

Quick links